Inventions, patentable

J. Rosenstock, Eaw of Chemical and Pharmaceutical Invention Patent and Monpatent Protection, Littie, Brown and Co., Boston, Mass., 1993. 

As 1,2,5-thiadiazole analogues, potent HlV-1 reverse transcriptase inhibitors, some simple 1,2,5-oxadiazoles, compounds 4-6 (Fig. 9), have been synthesized using the traditional Wieland procedure as key for the heterocycle formation [121]. Such as thiadiazole parent compounds, derivative with chlorine atoms on the phenyl ring, i.e., 5, showed the best anti-viral activity. Selectivity index (ratio of cytotoxic concentration to effective concentration) ranked in the order of 5 > 6 > 4. The activity of Fz derivative 6 proved the N-oxide lack of relevance in the studied bioactivity. These products have been claimed in an invention patent [122]. On the other hand, compound 7 (Fig. 9) was evaluated for its nitric oxide (NO)-releasing property (see below) as modulator of the catalytic activity of HlV-1 reverse transcriptase. It was found that NO inhibited dose-dependently the enzyme activity, which is hkely due to oxidation of Cys residues [123]. 

Bfx, Fx, and related compoimds are the subject of a great munber of invention patents especially related to its uses in material sciences. For example, they were included in the formiflation as rubber additives [245,246], as inhibitors in the polymerization of aromatic vinyl monomers [247], as components in the igniting composition for inflation of airbags [248,249], as explosives [250-253], as soHd propellants [254], as burn-rate modifiers [255], and as liquid-crystalHne materials [256]. 

Patent medicine industry, 78 683 Patent office gazettes, printed, 78 210-211 Patent portfolio auditing, 78 185 compiling, 78 157 Patent protection, foreign, 78 191 Patent research, in fine chemical research and development, 77 425-426 Patents, 5 766 78 157-197. See also Foreign patents Invention Patentability Trade secrets article of manufacture category in, 78 166... 

IX. Employee-inventors shall participate to the extent of at least 10% in the income generated by their inventions. Patents obtained by an employee resulting from inventions developed on his own time, outside his assigned field of work, will be the property of the employee. 

XVIII. Upon termination, the employee shall be given custody of his central personnel file. Records remaining with the employer will consist simply of the name and address of the terminated employee and the period of service. Upon termination, an employee shall be delivered a document by the employer defining his residual rights in inventions, patents pending, and possible publications. 

The present invention (Patent U.S. 6,177,560) refers to a new process for the preparation of mometasone furoate carried out by esterifiication of the 17 hydroxy group of mometasone without prior protection of the 11 hydroxy group. Mometasone (30 g) was suspended in methylene chloride (300 ml) and the resulting suspension was cooled to 0-5°C. At this temperature triethylamine (57 ml) was added. 2-Furoyl chloride (24 ml) was then added slowly. The mixture was then stirred at 8-12°C until the level of mometasone present was lower than 0.2% by HPLC. The reaction solution was then cooled to between -5-5°C and water (120 ml) was added with stirring. After stirring for 1 hour at 10-15°C the mixture was cooled to between 0-5°C and concentrated hydrochloric acid was added to adjust the pH of the aqueous layer between 1 and 2. 

QDO, PDO, and related compounds are the subject of a great number of invention patents, particularly for its uses in material sciences. For example, QDOs were included in the formulation of modified unsaturated polymers and rubbers [174,175]. Polymers with a QDO substructure as monomeric unit were used to produce fibers, films, electrochromic elements, electrodes, semiconductors, and electrolyte solutions for secondary batteries [176-179]. 

As the patent system harmonizes and more countries recognize the importance of patenting intellectual property, the value of patents grows. This leads to more people and companies seeking patents for even the most abstruse and maybe bizarre inventions. Patents issued by the U.S. Patent Office can be viewed in some large libraries or on the Web at www.uspto.gov. The following patents indicate there are no limits to human imagination ... 

Export parts which are assembled outside the U.S. to make an invention patented in the U.S., 271(f)... 

Altshuller found that each of the most inventive patents primarily solved an inventive problem, which he defined as those which contain conflicting requirements, which he called contradictions . 

Is the invention patentable in those countries which represent the major... 

The first US Patent was issued to inventor John Ruggles on July 13, 1836 for improved Traction Wheels for locomotive-engines. The Traction Wheels addressed the need for locomotives to efficiently climb inclined plains and hills with heavy loads drawn up to the same with more facility and economy than heretofore. US Patent 130 was the first chemical invention patent issued on February 16, 1837 to English chemist Webster Flockton. Flockton had developed a method of preserving wood by treating lumber with the essential oil of vegetable tar saturated with the oxide of iron. ... 

Likewise, another company whose technology may be based on a patent described in this chapter is T.R. Environtech Co. Ltd (www.trrecycling.co.kr). A Korea-based firm, their website mentions that their technology is based on the work performed by the person who some years earfier invented Patent US 4,118,282. However, even though the company claims to have a process for the low temperature pyrolysis for tyre waste and rubber waste , the website does not mention microwaves as the heat somce for the process. 

Pursuing excellence. Combines posstbilily with rationalism. Builds expcrti.se. Knowledge and inl ortnalion is fundamental. Builds vision, Kmphasis on inventions, patents, creative theories, sciemilie discoveries. 

Rosenstock, J. The Law of Chemical and Pharmaceutical Invention Patent and Non-Patent Protection, 2nd Ed. Aspen Law and Business New York, 2000. 

Berle, A. B., Sprague de Camp, L., Inventions, Patents and Their Management, Van Nostrand, New York, 1959. ... 

Meinhard, P., Invention, Patents, and Monopoly, Stevens and Sons, London, 1946. 

Most chemists at some time or other conceive patentable inventions. Patent memoranda describing these inventions are usually written to establish the necessary record for subsequent prosecution, by the patent attorney, of application for letters patent upon the invention. It is necessary for the attorney to know the closest art, if he is to obtain the best possible coverage in the claims he uses to describe the invention. The inventor should, if possible, therefore, supplement his patent mem,orandum with a few references which define the art closest to his invention. Some companies require this procedure. 

B. Straight patent licensing (in which a corporation is seeking a license to use existing university owned inventions, patents and applications). 

Illarionov BA, Tyulkova NA. Escherichia coli bacterial strain SL-60 - producer of bacterial luciferase. Invention Patent 1997 N 2073714. 

Inventions patented by Ostrejko13 in 1900 and 1901 paved the way for the development of modem commercial activated carbons. In one patent he described a basic process in which metallic chlorides were incorporated with vegetable substances and the mixture then carbonized at a suitable temperature. In another patented process, vegetable charcoal was heated at bright red heat with the simultaneous action of carbon dioxide. 

To foresee that a compound acting by a particular pharmacological mechanism can treat a specific human disease reflects a certain inventiveness. Patents therefore include method-of-use claims in which, for example, an anti-inflammatory substance relieves arthritis. Method claims may also extend to the use of compounds for diagnosing, monitoring, and preventing... 

First-to-File versus First-to-Invent. The United States applies a first-to-invent patent system, which means that if two different patent applications describe the same invention, the patent right will be issued to the invention that can be proven to have been invented first [84]. By contrast, the patent law of Canada, the EPO, and Japan, impose a first-to-file system, meaning that if two patent applications for the same invention are filed, the patent right will be granted to the applicant who filed an application at the earliest date [85], which is true even if the two identical inventions were arrived at independently. For this reason, first-to-file systems are often referred to as creating a high stakes race [86]. 

Mossinghoff G (2005). Small Entities and the First to Invent Patent System An Empirical Analysis. Washington Legal Foundation. Available http //www.wlf.org/ upload/MossinghoffWP.pdf. Accessed 20 July 2006. 

---